Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

Cancer - United States
doi 10.1002/cncr.30917
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Reduced PLCG1 Expression Is Associated With Inferior Survival for Myelodysplastic Syndromes

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Reprogramming Identifies Functionally Distinct Stages of Clonal Evolution in Myelodysplastic Syndromes

Blood
BiochemistryImmunologyCell BiologyHematology
2019English

The Myelodysplastic Syndromes: Diagnosis, Prognosis and Therapy

Italian Journal of Medicine
Medicine
2013English

Impaired Formation of Erythroblastic Islands Is Associated With Erythroid Failure and Poor Prognosis in a Significant Proportion of Patients With Myelodysplastic Syndromes

Haematologica
Hematology
2016English

Deferasirox Therapy Is Associated With Reduced Mortality Risk in a Medicare Population With Myelodysplastic Syndromes

Journal of Comparative Effectiveness Research
Health Policy
2015English

Clinicohematological and Cytogenetic Profile of Myelodysplastic Syndromes in Pakistan – Compare and Contrast

Leukemia Research
Cancer ResearchOncologyHematology
2017English

Cellularity, Characteristics of Hematopoietic Parameters and Prognosis in Myelodysplastic Syndromes

European Journal of Haematology
MedicineHematology
2015English

Microarray Profiling Defines Circulating microRNAs Associated With Myelodysplastic Syndromes

Neoplasma
Cancer Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy